Low-dose ultraviolet al phototherapy for treating pityriasis rosea

Annals of Dermatology

Volumn 21, Issue 3, 2009, Pages 230-236

  Lim, Sang Hee ^a   Kim, Sang Min ^a   Oh, Byung Ho ^a   Ko, Jong Hyun ^a   Lee, Yang Won ^a   Choe, Yong Beom ^a   Ahn, Kyu Joong ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

Pityriasis rosea severity score; Rosea; UVA

Indexed keywords

EID: 70350322287     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2009.21.3.230     Document Type: Article

References (40)

1. Chuh AA, Chiu SS, Peiris JS. Human herpesvirus 6 and 7 DNA in peripheral blood leucocytes and plasma in patients with pityriasis rosea by polymerase chain reaction: a prospective case control study. Acta Derm Venereol 2001; 81:289-290.
2. Wong WR, Tsai CY, Shih SR, Chan HL. Association of pityriasis rosea with human herpesvirus-6 and human herpesvirus-7 in Taipei. J Formos Med Assoc 2001 ;100:478-483.
3. Drago F, Ranieri E, Malaguti F, Battifoglio ML, Losi E, Rebora A. Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin. Dermatology 1997;195:374-378.
4. Cheong WK, Wong KS. An epidemiological study of pityriasis rosea in Middle Road Hospital. Singapore Med J 1989;30:60-62.
5. Stulberg DL, Wolfrey J. Pityriasis rosea. Am Fam Physician 2004;69:87-91.
6. Gonzalez LM, Allen R, Janniger CK, Schwartz RA. Pityriasis rosea: an important papulosquamous disorder. Int J Dermatol 2005;44:757-764.
7. Alf B, Eva T. Pityriasis rosea. In: Freedberg IM, Eisen AZ, Wolf K, Austen KF, Goldsmith LA, Katz SI, editors. Fitz- patrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2003:445-449.
8. Merchant M, Hammond R. Controlled study of ultraviolet light for pityriasis rosea. Cutis 1974;14:548-549.
9. Baden HP, Provan J. Sunlight and pityriasis rosea. Arch Dermatol 1977;113:377-378.
10. Plemmons JA. Pityriasis rosea: an old therapy revisited. Cutis 1975;16:120-121.
11. Arndt KA, Paul BS, Stern RS, Parrish JA. Treatment of pityriasis rosea with UV radiation. Arch Dermatol 1983;119: 381-382.
12. Dawe RS. Ultraviolet A1 phototherapy. Br J Dermatol 2003;148:626-637.
13. Beattie PE, Dawe RS, Ibbotson SH, Ferguson J. UVA1 phototherapy for treatment of necrobiosis lipoidica. Clin Exp Dermatol 2006;31:235-238.
14. Abeck D, Schmidt T, Fesq H, Strom K, Mempel M, Brockow K, et al. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. J Am Acad Dermatol 2000;42: 254-257.
15. Kowalzick L. UVA1 for atopic dermatitis: medium dose superior to low dose. J Am Acad Dermatol 2001;44:548.
16. Krutmann J, Diepgen TL, Luger TA, Grabbe S, Meffert H, Sonnichsen N, et al. High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol 1998;38:589-593.
17. Grabbe J, Welker P, Humke S, Grewe M, Schopf E, Henz BM, et al. High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol 1996;107:419-422.
18. Camacho NR, Sanchez JE, Martin RF, Gonzalez JR, Sanchez JL. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells. J Am Acad Dermatol 2001;45:697-699.
19. Gruss C, Stucker M, Kobyletzki G, Schreiber D, Altmeyer P, Kerscher M. Low dose UVA1 phototherapy in disabling pansclerotic morphoea of childhood. Br J Dermatol 1997;136:293-294.
20. de Rie MA, Enomoto DN, de Vries HJ, Bos JD. Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method. Dermatology 2003;207:298-301.
21. Kreuter A, Breuckmann F, Uhle A, Brockmeyer N, Von Kobyletzki G, Freitag M, et al. Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis. J Am Acad Dermatol 2004;50:740-747.
22. Kreuter A, Jansen T, Stucker M, Herde M, Hoffmann K, Altmeyer P, et al. Low-dose ultraviolet-A1 phototherapy for lichen sclerosus et atrophicus. Clin Exp Dermatol 2001;26: 30-32. (Pubitemid 32204841)
23. Kreuter A, Gambichler T, Avermaete A, Happe M, Bacharach-Buhles M, Hoffmann K, et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol 2002;46: 251-255.
24. Grundmann-Kollmann M, Behrens S, Gruss C, Gottlober P, Peter RU, Kerscher M. Chronic sclerodermic graft-versus- host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy. J Am Acad Dermato2000;42:134-136.l
25. Stander H, Schiller M, Schwarz T. UVA1 therapy for sclerodermic graft-versus-host disease of the skin. J Am Acad Dermatol 2002;46:799-800.
26. Schaller M, Romiti R, Wollenberg A, Prinz B, Woerle B. Improvement of cutaneous manifestations in POEMS syndrome after UVA1 phototherapy. J Am Acad Dermatol 2001;45:969-970.
27. Molina JF, McGrath H Jr. Longterm ultraviolet-A1 irradiation therapy in systemic lupus erythematosus. J Rheumatol 1997;24:1072-1074.
28. Stege H, Schopf E, Ruzicka T, Krutmann J. High-dose UVA1 for urticaria pigmentosa. Lancet 1996;347:64.
29. Plotz SG, Abeck D, Seitzer U, Hein R, Ring J. UVA1 for hypereosinophilic syndrome. Acta Derm Venereol 2000; 80:221.
30. Muchenberger S, Schopf E, Simon JC. Phototherapy with UV-A-I for generalized granuloma annulare. Arch Dermatol 1997;133:1605.
31. Mahnke N, Medve-Koenigs K, Berneburg M, Ruzicka T, Neumann NJ. Cutaneous sarcoidosis treated with medium- dose UVA1. J Am Acad Dermatol 2004;50:978-979.
32. Asawanonda P, Khoo LS, Fitzpatrick TB, Taylor CR. UV-A1 for keloid. Arch Dermatol 1999;135:348-349.
33. von Kobyletzki G, Kreuter JA, Nordmeier R, Stucker M, Altmeyer P. Treatment of idiopathic mucinosis follicularis with UVA1 cold light phototherapy. Dermatology 2000;201: 76-77.
34. Pinton PC, Capezzera R, Zane C, De Panfilis G. Medium- dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica. J Am Acad Dermatol 2002;47:410-414.
35. Zane C, Leali C, Airo P, De Panfilis G, Pinton PC. "High- dose" UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides. J Am Acad Dermatol 2001;44:629-633.
36. Leenutaphong V, Jiamton S. UVB phototherapy for pityriasis rosea: a bilateral comparison study. J Am Acad Dermatol 1995;33:996-999.
37. Tuchinda C, Kerr HA, Taylor CR, Jacobe H, Bergamo BM, Elmets C, et al. UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States. Photo- dermatol Photoimmunol Photomed 2006;22:247-253.
38. Aiba S, Tagami H. Immunohistologic studies in pityriasis rosea. Evidence for cellular immune reaction in the lesional epidermis. Arch Dermatol 1985;121:761-765.
39. Sugiura H, Miyauchi H, Uehara M. Evolutionary changes of immunohistological characteristics of secondary lesions in pityriasis rosea. Arch Dermatol Res 1988;280:405-410.
40. Morita A, Werfel T, Stege H, Ahrens C, Karmann K, Grewe M, et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 1997;186:1763-1768.